WATERTOWN, Mass., June 20, 2023 C4 Therapeutics, Inc. , a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of. | June 20, 2023
Electric vehicle
maker Rivian said it has agreed to adopt Tesla s
charging standard, giving customers access to the
biggest U.S. charging network and adding momentum to Tesla s bid
to set the industry. | June 20, 2023
Adagrasib is the first and only KRASG12C inhibitor to prospectively demonstrate intracranial activity in KRASG12C-mutated NSCLC with untreated CNS metastases
Data demonstrate compelling. | June 20, 2023